Company

Timberlyne Therapeutics

https://timberlyne-tx.com/

Industryclinical-stage biopharmaceutical company focused on the development of new therapies for autoimmune disorders

Funding raised

CompanyRoundDate
Timberlyne TherapeuticsSeries A2025-01-10